Researchers have developed a universal, base-edited CAR T-cell treatment that delivers high remission rates for patients with resistant T-cell leukemia. Early outcomes—and remarkable recoveries—suggest a powerful new path forward against this aggressive cancer. Breakthrough gene-edited treatment for T-cell leukemia Scientists at UCL (University College London) and Great Ormond Street Hospital (GOSH) have developed a new …
Read More
About The Author
